Pharmacogenetics of CYP enzymes and drug transporters: Remarkable recent advances

Advanced Drug Delivery Reviews

Volumn 54, Issue 10, 2002, Pages 1241-1242

  Kim, Richard B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CARRIER PROTEIN; CYTOCHROME P450; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; GLYCOPROTEIN P; NICOTINE; ABC TRANSPORTER; DRUG;

ACETYLATOR PHENOTYPE; DNA POLYMORPHISM; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSPORT; DRUG UPTAKE; EDITORIAL; GENE ACTIVITY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICOKINETICS; BIOTRANSFORMATION; DRUG DELIVERY SYSTEM; GENETICS; METABOLISM; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS;

EID: 0037131888     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00167-9     Document Type: Editorial

References (9)

1. Kuehl P., Zhang J., Lin Y., et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27:2001;383-391.
2. Dickmann L.J., Rettie A.E., Kneller M.B., Kim R.B., Wood A.J., Stein C.M., Wilkinson G.R., Schwarz U.I. Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol. Pharmacol. 60:2001;382-387.
3. Thummel K.E., Wilkinson G.R. In vitro and in vivo drug interactions involving human CYP3A. Ann. Rev. Pharmacol. Toxicol. 38:1998;389-430.
4. Kim R.B. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab. Rev. 34:2002;47-54.
5. Schinkel A.H. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Del. Rev. 36:2000;179-194.
6. Schuetz J.D., Connelly M.C., Sun D., Paibir S.G., Flynn P.M., Srinivas R.V., Kumar A., Fridland A. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med. 5:1999;1048-1051.
7. Meier P.J., Eckhardt U., Schroeder A., Hagenbuch B., Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology. 26:1997;1667-1677.
8. Gao B., Hagenbuch B., Kullak-Ublick G.A., Benke D., Aguzzi A., Meier P.J. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. 294:2000;73-79.
9. Tirona R.G., Leake B.F., Merino G., Kim R.B. Polymorphisms in OATP-C: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J. Biol. Chem. 276:2001;35669-35675.